X-ray analysis of functionalized cyclooctanes provided proof of conformational preferences in these medium rings. Significantly ...

Goodburn, R. J., Philippens, M. E. P., Lefebvre, T. L., Khalifa, A., Bruijnen, T., Freedman, J. N., Waddington, D. E. J., Younus, E., Aliotta, E., Meliadò, G., Stanescu, T., Bano, W., Fatemi-Ardekani, A., Wetscherek, A., Oelfke, U., van den Berg, N., Mason, R. P., van Houdt, P. J., Balter, J. M. & Gurney-Champion, O. J., Dec 2022, In: Magnetic resonance in medicine. 88, 6, p. 2592-2608 17 p.. Research output: Contribution to journal › Article › peer-review ...

MeSH headings : Actins / chemistry; Actins / metabolism; CSK Tyrosine-Protein Kinase; Cyclooctanes / chemistry; Cytoplasm / ...

Thiadiazoles *Cyclooctanes Amyloid Precursor Protein Secretases/antagonists & inhibitors. J Med Chem 2009 Jun 11;52(11):3441-4 ...

Cyclooctanes [D02.455.426.392.368.408] Cyclooctanes * Cyclopentanes [D02.455.426.392.368.450] Cyclopentanes * Cyclopropanes [ ...

Alicyclic hydrocarbons in which three or more of the carbon atoms in each molecule are united in a ring structure and each of the ring carbon atoms is joined to two hydrogen atoms or alkyl groups. The simplest members are cyclopropane (C3H6), cyclobutane (C4H8), cyclohexane (C6H12), and derivatives of these such as methylcyclohexane (C6H11CH3). (From Sax, et al., Hawleys Condensed Chemical Dictionary, 11th ed ...

Lam HM, Ouyang B, Chen J, Ying J, Wang J, Wu CL, Jia L, Medvedovic M, Vessella RL, Ho SM. Targeting GPR30 with G-1: a new therapeutic target for castration-resistant prostate cancer. Endocr Relat Cancer. 2014; 21(6):903-14 ...

Cyclooctanes [D02.455.426.392.368.408] * Cyclopentanes [D02.455.426.392.368.450] * Cycloleucine [D02.455.426.392.368.450.350] ...

Animals , Mice , Rats , Cyclooctanes , Lignans , Lipids , Lung Neoplasms/drug therapy , Nanoparticles , Polycyclic Compounds , ... Animals , Rats , Apoptosis , Brain/pathology , Brain Injuries/pathology , Caspase 3/metabolism , Cyclooctanes , Evans Blue , ...